Effective Implementation of Bispecific Antibodies is organized by Healio, Horizon CME.
Release Date: September 22, 2025
Expiration Date: (12 months after release date): September 22, 2026
Description:
This multi-faculty CME course is the final installment in a three-part series offering an in-depth exploration of bispecific antibody therapy. In this installment, participants will gain expert insights on the practical implementation of outpatient administration strategies for bispecific antibodies with a focus on t-cell engagers. Through interactive presentations and expert panel discussions, participants will examine outpatient care models with an emphasis on infrastructure needs, patient monitoring, and multidisciplinary collaboration. The activity also addresses the financial and logistical considerations involved in transitioning from inpatient to outpatient bispecific antibody delivery, providing actionable guidance for implementation in clinical practice. Clinical pearls for managing patients outside the traditional inpatient setting will be shared throughout to reinforce key takeaways.
Educational Objectives:
Upon completion of the educational activity, participants should be able to:
Credits:
Physician Continuing Education:
In support of improving patient care, this activity has been planned and implemented by Horizon CME. Horizon CME is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Designation Statement:
0.75 ACPE Pharmacy
The Washington State Pharmacy Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This online education is approved for up to 0.25 credit by the Washington State Pharmacy Association.
This activity is approved for up to 0.25 credit by the Washington State Pharmacy Association. Activity Type: Online | Start/End date: 10/22/2025-9/22/2026. The Washington State Pharmacy Association (WSPA) is accredited by the Accreditation Council for Pharmacy Education as a Provider of continuing pharmacy education. NOTE FOR PHARMACISTS: It is the responsibility of the pharmacist or pharmacy technician to provide the correct information [NABP eProfile ID and DOB (in MMDD format)] within the evaluation, in order to receive credit for participating in this CPE activity. Following the activity’s end date, there is a maximum of 60 days allowed to upload the CPE information to the CPE Monitor. WSPA will upload the CPE information to the CPE monitor 50 days after the activity – please check your CPE Monitor at this time to ensure the CPE is uploaded in your profile.
0.75 AMA PRA Category 1 Credit™
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME). Horizon CME is accredited by the ACCME to provide continuing medical education for physicians.
Horizon CME designates this online activity for a maximum of 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
0.75 ANCC
This activity has been submitted to Montana Nurses Association for approval to award contact hours. Montana Nurses Association is accredited with distinction as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. This activity is accredited from 10/22/2025-9/22/2026.
0.25 Pharmacology
This activity has been submitted to Montana Nurses Association for approval to award contact hours. Montana Nurses Association is accredited with distinction as an approver of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation. Upon completion, NPs and RNs will be awarded up to 0.25 credit. This activity is accredited from 10/22/2025-9/22/2026.
Copyrights © 2026 eMedEvents Corporation, All Rights Reserved